New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 16 04:00PM ET
4.74
Dollar change
-0.07
Percentage change
-1.56
%
IndexRUT P/E- EPS (ttm)-3.62 Insider Own7.83% Shs Outstand52.75M Perf Week6.64%
Market Cap249.83M Forward P/E- EPS next Y-3.27 Insider Trans-0.02% Shs Float48.63M Perf Month22.04%
Enterprise Value278.62M PEG- EPS next Q-1.07 Inst Own79.23% Short Float4.55% Perf Quarter117.20%
Income-190.63M P/S- EPS this Y-18.63% Inst Trans4.01% Short Ratio5.41 Perf Half Y-39.37%
Sales0.00M P/B2.29 EPS next Y17.82% ROA-52.04% Short Interest2.21M Perf YTD-52.41%
Book/sh2.06 P/C1.80 EPS next 5Y-1.70% ROE-108.92% 52W High11.60 -59.18% Perf Year57.83%
Cash/sh2.63 P/FCF- EPS past 3/5Y13.38% -21.78% ROIC-71.79% 52W Low1.92 146.61% Perf 3Y-45.70%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility11.49% 8.11% Perf 5Y-91.14%
Dividend TTM- EV/Sales- EPS Y/Y TTM18.41% Oper. Margin- ATR (14)0.37 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.62 Sales Y/Y TTM- Profit Margin- RSI (14)63.06 Recom3.80
Dividend Gr. 3/5Y- - Current Ratio4.62 EPS Q/Q-32.92% SMA2018.13% Beta2.35 Target Price7.25
Payout- Debt/Eq1.54 Sales Q/Q- SMA5021.32% Rel Volume0.51 Prev Close4.81
Employees109 LT Debt/Eq1.44 EarningsMay 14 AMC SMA200-2.26% Avg Volume409.01K Price4.74
IPOOct 04, 2018 Option/ShortYes / Yes EPS/Sales Surpr.-21.94% - Trades Volume207,919 Change-1.56%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Upgrade Jefferies Hold → Buy $20
Sep-05-24Initiated H.C. Wainwright Neutral $3
Dec-11-23Resumed Goldman Sell $2
Nov-17-23Upgrade CapitalOne Equal Weight → Overweight $7 → $12
Jul-27-23Downgrade UBS Buy → Neutral $15 → $4
Jul-25-23Downgrade JP Morgan Neutral → Underweight
Jul-25-23Downgrade Chardan Capital Markets Buy → Neutral
Jul-24-23Downgrade Jefferies Buy → Hold
Jul-24-23Downgrade CapitalOne Overweight → Equal Weight $7
Nov-15-22Initiated CapitalOne Overweight $24
Jul-10-25 08:00AM
Jun-25-25 04:45PM
Jun-24-25 05:51AM
Jun-13-25 11:30AM
May-29-25 09:32PM
11:04AM Loading…
May-15-25 11:04AM
May-14-25 04:15PM
May-01-25 11:43PM
Apr-01-25 09:35AM
Mar-28-25 09:45AM
Mar-27-25 04:01PM
Mar-26-25 03:58PM
Mar-10-25 04:39PM
Feb-04-25 07:30AM
Jan-13-25 04:26PM
06:00AM Loading…
Jan-07-25 06:00AM
Dec-09-24 09:18PM
12:33PM
Nov-25-24 09:55AM
Nov-14-24 04:01PM
Nov-11-24 06:15AM
Oct-14-24 05:35PM
Sep-23-24 06:00AM
Sep-17-24 04:05PM
Sep-13-24 11:30AM
Aug-16-24 10:42AM
Aug-14-24 09:54PM
04:01PM
Jul-10-24 12:00PM
Jun-20-24 08:23AM
11:30AM Loading…
Jun-14-24 11:30AM
May-29-24 04:36PM
May-16-24 12:51PM
May-15-24 10:55PM
04:01PM
May-14-24 07:31AM
May-13-24 07:32PM
May-02-24 04:30PM
Apr-04-24 12:09PM
Apr-01-24 05:04PM
12:00PM
Mar-29-24 10:36AM
Mar-28-24 11:53AM
08:32AM
06:30AM
Mar-26-24 06:15AM
Jan-30-24 06:30AM
Jan-04-24 04:15PM
Dec-14-23 11:30AM
Nov-21-23 04:15PM
Nov-15-23 08:00AM
Nov-14-23 06:09PM
04:01PM
Nov-06-23 05:00AM
Nov-01-23 11:21PM
Oct-17-23 01:44AM
Oct-11-23 06:00AM
Sep-13-23 11:30AM
Sep-08-23 06:00AM
Sep-07-23 06:00AM
Aug-16-23 10:26AM
Aug-14-23 07:31PM
04:01PM
08:34AM
07:15AM
Aug-02-23 10:09AM
Jul-27-23 02:30AM
Jul-26-23 06:42AM
Jul-25-23 09:16AM
Jul-24-23 06:26AM
06:09AM
06:00AM
Jun-14-23 11:30AM
May-30-23 04:15PM
11:14AM
May-16-23 07:44AM
May-15-23 04:01PM
Apr-27-23 11:30AM
Apr-21-23 07:30AM
Apr-11-23 06:29AM
Apr-04-23 01:16PM
Apr-03-23 11:38AM
07:30AM
Mar-28-23 04:08PM
Mar-01-23 05:55AM
Feb-09-23 07:30AM
Jan-04-23 07:00AM
Dec-09-22 11:30AM
Nov-30-22 09:55AM
Nov-16-22 04:30PM
Nov-14-22 09:55AM
Nov-10-22 02:17PM
Nov-09-22 04:01PM
Nov-02-22 06:24AM
Sep-22-22 06:06AM
Sep-08-22 11:30AM
Sep-07-22 04:05PM
Aug-26-22 01:34PM
Aug-19-22 12:32PM
Aug-18-22 05:47PM
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BORGESON JOHN A.See RemarksJun 17 '25Sale3.657232,640183,316Jun 17 08:15 PM